{
    "URL": "https://doi.org/10.1371/journal.pntd.0008171",
    "Published": "March 23, 2020",
    "Subject_Areas": [
        "Enzyme-linked immunoassays",
        "Phase I clinical investigation",
        "Vaccine development",
        "Antibodies",
        "Typhoid",
        "Vaccines",
        "Conjugate vaccines",
        "Phase III clinical investigation"
    ],
    "Authors": {
        "Eun Young Lee": [
            "Clinical Research Laboratory, International Vaccine Institute, Seoul, Republic of Korea"
        ],
        "Ju Yeon Park": [
            "Biostatistics & Data Management, International Vaccine Institute, Seoul, Republic of Korea"
        ],
        "Deok Ryun Kim": [
            "Biostatistics & Data Management, International Vaccine Institute, Seoul, Republic of Korea"
        ],
        "Manki Song": [
            "Clinical Research Laboratory, International Vaccine Institute, Seoul, Republic of Korea"
        ],
        "Sushant Sahastrabuddhe": [
            "Development and Delivery, International Vaccine Institute, Seoul, Republic of Korea"
        ],
        "Hun Kim": [
            "SK Bioscience, Seongnam, Republic of Korea"
        ],
        "Yun Chon": [
            "Biostatistics & Data Management, International Vaccine Institute, Seoul, Republic of Korea",
            "Amgen Inc., Thousand Oaks, California, United States of America"
        ],
        "Jae Seung Yang": [
            "Clinical Research Laboratory, International Vaccine Institute, Seoul, Republic of Korea"
        ]
    }
}